Intellia Therapeutics Investor

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Technology: Cell-based gene therapy, Cell_Therapies
Industry: Gene therapy, Public
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2014-01-01
Employees Number: 501-1000
Funding Status: IPO
Number Of Exits: -
Investors Number: 9
Total Funding: 1225000030
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-11-30
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership